The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
MicroRNA therapeutics: Discovering novel targets and developing specific therapy
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“They are small molecules frequently conserved among species208 that are remarkably stable in plasma and serum due to high resistance to RNase activity and degradation.209”
From MiR-128-3p – a gray eminence of the human central nervous system (2024) · cites this paper as [208]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14
Lee, R. C., Feinbaum, R. L., & Ambros, V. (1993) · Cell · doi:10.1016/0092-8674(93)90529-y · Cited by 12,948
Rayner, K. J., Sheedy, F. J., Esau, C. C., Hussain, F. N., Temel, R. E., Parathath, S., van Gils, J. M., Rayner, A. J., Chang, A. N., Suarez, Y., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57275 · Cited by 690 · cited 1×
“In a study, mice deficient for the low-density lipoprotein receptor (LDLr–/– mice), with established atherosclerotic plaques treated with anti-miR33 for 4 weeks, showed an increase in circulating HDL levels and enhanced reverse cholesterol transport to the plasma, liver, and feces.[13] Consistent with this, anti-miR33…”
BackgroundmiR-33 links SREBP-2 induction to repression of sterol transporters
Marquart, T. J., Allen, R. M., Ory, D. S., & Baldán, Á. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1005191107 · Cited by 562
Research works printed but not linked: 16
- Bader, 2010, The promise of microRNA replacement therapy, Cancer Res, 7027
- Czech, 2006, MicroRNAs as therapeutic targets, N Engl J Med, 1194
- Reinhart, 2000, The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans, Nature, 901
- Lu, 2005, MicroRNA expression profiles classify human cancers, Nature, 834
- Johnson, 2005, RAS is regulated by the let-7 microRNA family, Cell, 635
- Jopling, 2008, Position-dependent function for a tandem microRNA miR-122-binding site located in the hepatitis C virus RNA genome, Cell Host Microbe, 77
- Jopling, 2005, Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA, Science, 1577
- Dorsett, 2008, MicroRNA-155 suppresses activation-induced cytidine deaminase-mediated Myc-Igh translocation, Immunity, 630
- Li, 2013, Rheumatoid arthritis-associated microRNA-155 targets SOCS1 and upregulates TNF-a and IL-1ß in PBMCs, Int J Mol Sci, 23910
- Guessous, 2013, Oncogenic effects of miR-10b in glioblastoma stem cells, J Neurooncol, 153
- Aravalli, 2013, Development of MicroRNA Therapeutics for hepatocellular carcinoma, Diagnostics (Basel), 170
- Xu, 2011, Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis, Mol Carcinog, 136
- Vidal, 2005, Making sense of antisense, Eur J Cancer, 2812
- Fabani, 2010, Efficient inhibition of miR-155 function in vivo by peptide nucleic acids, Nucleic Acids Res, 4466
- Lee, 2012, Self-assembled RNA interference microsponges for efficient siRNA delivery, Nat Mater, 316
- Bader, 2012, miR-34 – A microRNA replacement therapy is headed to the clinic, Front Genet, 120
Cited by
Sorted by citations
Advances in the delivery of RNA therapeutics: from concept to clinical reality
Kaczmarek, J. C., Kowalski, P. S., & Anderson, D. G. (2017) · Genome Medicine · doi:10.1186/s13073-017-0450-0 · Cited by 656
miRNAs regulate the HIF switch during hypoxia: a novel therapeutic target
Serocki, M., Bartoszewska, S., Janaszak-Jasiecka, A., Ochocka, R. J., Collawn, J. F., & Bartoszewski, R. (2018) · Angiogenesis · doi:10.1007/s10456-018-9600-2 · Cited by 288
Inflammasome Priming in Sterile Inflammatory Disease
Patel, M. N., Carroll, R. G., Galván-Peña, S., Mills, E. L., Olden, R., Triantafilou, M., Wolf, A. I., Bryant, C. E., Triantafilou, K., & Masters, S. L. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.12.007 · Cited by 241
MiR-128-3p – a gray eminence of the human central nervous system
Kiel, K., Król, S. K., Bronisz, A., & Godlewski, J. (2024) · Molecular Therapy Nucleic Acids · doi:10.1016/j.omtn.2024.102141 · Cited by 15
Metadata
- Authors
- Bansal, P., Christopher, A., Kaur, R., Kaur, G., Kaur, A., & Gupta, V.
- Venue
- Perspectives in Clinical Research
- Published
- 2016
- Volume
- 7
- Issue
- 2
- Pages
- 68
- ISSN
- 2229-3485
- PMC
- PMC4840794
- Cited by
- 360
- References
- 3
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
